NDC 59137-525

Rasuvo

Methotrexate

Rasuvo is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Medexus Pharma Inc.. The primary component is Methotrexate Sodium.

Product ID59137-525_6493ca6b-d3f7-419c-91b8-87eb185f77c9
NDC59137-525
Product TypeHuman Prescription Drug
Proprietary NameRasuvo
Generic NameMethotrexate
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2014-07-10
Marketing CategoryNDA / NDA
Application NumberNDA205776
Labeler NameMedexus Pharma Inc.
Substance NameMETHOTREXATE SODIUM
Active Ingredient Strength18 mg/.35mL
Pharm ClassesFolate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 59137-525-01

1 PACKAGE in 1 CARTON (59137-525-01) > .35 mL in 1 PACKAGE (59137-525-00)
Marketing Start Date2014-07-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59137-525-04 [59137052504]

Rasuvo INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA205776
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-07-10

NDC 59137-525-01 [59137052501]

Rasuvo INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA205776
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-07-10

NDC 59137-525-00 [59137052500]

Rasuvo INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA205776
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-07-10

Drug Details

Active Ingredients

IngredientStrength
METHOTREXATE SODIUM17.5 mg/.35mL

OpenFDA Data

SPL SET ID:d0075461-0e7e-4967-9c9b-d6440e912c0e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1544386
  • 1544387
  • 1544378
  • 1544383
  • 1544402
  • 1544388
  • 1544389
  • 1544401
  • 1544398
  • 1544403
  • 1544385
  • 1441416
  • 1544404
  • 1544390
  • 1544395
  • 1544394
  • 1544397
  • 1544396

    • Pharmacological Class

    • Folate Analog Metabolic Inhibitor [EPC]
    • Folic Acid Metabolism Inhibitors [MoA]

    NDC Crossover Matching brand name "Rasuvo" or generic name "Methotrexate"

    NDCBrand NameGeneric Name
    59137-520RasuvoRasuvo
    59137-550RasuvoRasuvo
    59137-510RasuvoRasuvo
    59137-525RasuvoRasuvo
    59137-530RasuvoRasuvo
    59137-515RasuvoRasuvo
    59137-535RasuvoRasuvo
    59137-540RasuvoRasuvo
    59137-505RasuvoRasuvo
    0143-9367MethotrexateMethotrexate
    0143-9516MethotrexateMethotrexate
    0143-9517MethotrexateMethotrexate
    0143-9518MethotrexateMethotrexate
    0143-9519MethotrexateMethotrexate
    0143-9830MethotrexateMethotrexate
    0378-0014Methotrexatemethotrexate
    0555-0572MethotrexateMethotrexate
    0703-3671MethotrexateMethotrexate
    0703-3675MethotrexateMethotrexate
    0703-3678MethotrexateMethotrexate

    Trademark Results [Rasuvo]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    RASUVO
    RASUVO
    86152434 4672924 Live/Registered
    Medac Pharma, Inc.
    2013-12-26
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.